Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH

Oldenburg 26133

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Triple-negative Breast Cancer

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer — Completed